Author

Jason Bell

University of MinnesotaPrimary ORCID profile (0000-0002-1583-5292 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Jason BelliD1 paper · The University of Western Australia

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Andrew T. CraneiD· 1 shared Beau R. WebberiD· 1 shared Bibekananda KariD· 1 shared Branden S. MoriarityiD· 1 shared Bryce J. WickiD· 1 shared Erin M. Stelljes· 1 shared Jacob E. Bridge· 1 shared Jihyun Kim· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Andrew T. CraneORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Efficient multiplex non-viral engineering and expansion of polyclonal γδ CAR-T cells for immunotherapy

Jacob E. Bridge, Matthew J. Johnson, Bibekananda Kar, Jihyun Kim, Sophia J. Wenthe, Joshua B. Krueger, Bryce J. Wick, Mitchell G. Kluesner, Andrew T. Crane, Jason Bell, Lage von Dissen, Erin M. Stelljes, Joseph G. Skeate, Branden S. Moriarity, Beau R. Webber

This paper develops a scalable, non-viral method to engineer and expand polyclonal γδ CAR-T cells, showing their functional efficacy and subset-specific responses in vivo.

Molecular Therapy · Mar 11, 2026Peer-reviewedImmunology